A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan.
- DOI
- 10.1016/j.orcp.2026.09.001
- Published
- 2026 Sep 15
- Container
- Obesity research & clinical practice
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.orcp.2026.09.001,
title = {A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan.},
author = {Chiu CF and Chou CK and Hu SW and Huang KC and Wu YL and Wu HF and Liu YL and Yang YC and Chen HL and Yeung CY},
year = {2026},
journal = {Obesity research \& clinical practice},
doi = {10.1016/j.orcp.2026.09.001},
url = {https://doi.org/10.1016/j.orcp.2026.09.001}
}RIS
TY - JOUR TI - A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan. AU - Chiu CF AU - Chou CK AU - Hu SW AU - Huang KC AU - Wu YL AU - Wu HF AU - Liu YL AU - Yang YC AU - Chen HL AU - Yeung CY PY - 2026 JO - Obesity research & clinical practice DO - 10.1016/j.orcp.2026.09.001 UR - https://doi.org/10.1016/j.orcp.2026.09.001 ER -
APA
CF, C., CK, C., SW, H., KC, H., YL, W., HF, W., YL, L., YC, Y., HL, C., & CY, Y. (2026). A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan.. Obesity research & clinical practice. https://doi.org/10.1016/j.orcp.2026.09.001
Source records
- pubmed · retrieved 2026-09-27T13:39:47.178Z